Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interactions: keeping it straight

G D Anastasio1, K O Cornell, D Menscer

  • 1Department of Family Practice, Carolinas Medical Center, Charlotte, N.C. 28232-2861, USA.

American Family Physician
|September 25, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromium: friend or foe?

Archives of family medicine·1999
Same author

Alendronate treatment to prevent osteoporotic fractures.

Archives of family medicine·1998
Same author

Mifepristone (RU 486): current knowledge and future prospects.

Archives of family medicine·1998
Same author

Salary survey of ambulatory care clinical pharmacists.

Pharmacotherapy·1997
Same author

Pharmaceutical marketing: implications for medical residency training.

Pharmacotherapy·1996
Same author

Ritalin for nicotine withdrawal: Nesbitt's paradox revisited.

Addictive behaviors·1995
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Drug interactions can cause treatment failure and adverse reactions, particularly in patients with chronic conditions or impaired kidney function. Understanding mechanisms like enzyme inhibition and altered metabolism is key to managing these risks.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Drug Metabolism

Background:

  • Drug interactions are a significant cause of treatment failure and adverse drug reactions.
  • Patients with multiple chronic conditions, polypharmacy, or renal impairment face elevated risks.
  • Drugs requiring therapeutic drug monitoring, due to their narrow safety margins, warrant particular attention.

Purpose of the Study:

  • To elucidate the common causes and mechanisms of drug interactions.
  • To highlight patient populations at increased risk.
  • To emphasize the importance of considering interaction timing and type.

Main Methods:

  • Review of known drug interaction mechanisms.
  • Identification of risk factors and susceptible patient groups.

Related Experiment Videos

  • Analysis of pharmacokinetic and pharmacodynamic interaction principles.
  • Main Results:

    • Drug interactions frequently arise from altered absorption, distribution, metabolism (cytochrome P450 system), and excretion.
    • Enzyme inhibitors (e.g., erythromycin, cimetidine) are common culprits.
    • Antagonistic and synergistic effects, alongside temporal aspects, influence clinical outcomes.

    Conclusions:

    • Comprehensive understanding of drug interaction mechanisms is crucial for safe and effective pharmacotherapy.
    • Risk stratification and vigilant monitoring are essential, especially for high-risk patients and narrow therapeutic index drugs.
    • Clinical decision-making must integrate knowledge of interaction types, mechanisms, and timing.